Eli Lilly & Co. (LLY) Handily Beats Q1 EPS, Revs Expectations; Boosts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts LLY Hot Sheet
Price: $1,209.00 -0.92%
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other - net, expense (income): -27.2M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $0.92, $0.14 better than the analyst estimate of $0.78. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.35 billion.
Eli Lilly & Co. sees FY2012 EPS of $3.15-$3.30, versus the consensus of $3.18. Eli Lilly & Co. sees FY2012 revenue of (n/a).
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Eli Lilly & Co. sees FY2012 EPS of $3.15-$3.30, versus the consensus of $3.18. Eli Lilly & Co. sees FY2012 revenue of (n/a).
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
